Follow-The-Filings

What the superinvestors bought and sold in 2024 Q4

136 of 137 filedholdings as of 31 Dec 2024as of today

2024 Q4

136 of 137 filed
Pick managers

Combine any featured managers. A manager counts once it has a book in both quarters.

2026 Q3 filings are coming in 0 of 137 filed · due 16 Nov See the early read

The quarter at a glance

82 of 134 managers were net sellers. Setting price aside, they took $52.7B out, led by Information Technology (−$23.2B), while adding to Health Care (+$7.9B). FERG was the most widely bought stock (7 bought, 0 sold); AMZN the most widely sold (23 sold, 11 bought).

Net buyers 47 of 134 managers 82 sold more than they bought · 5 about even
Net bought −$52.7B Price moves taken out; prices alone moved the book +$15.8B.
Positions opened 633 593 closed out. IPOs, spin-offs and mergers left out.
Combined book, last quarter +1.1% SPY +2.1%, 1.0 pts behind. Price only.

Most bought and sold

Ranked by net dollars bought or sold, with price moves taken out. Open a stock to see who.

Most bought

  1. 1 LLY Eli Lilly & Co. 8 bought · 3 sold +$1.7B
  2. 2 HUM Humana, Inc. 4 bought · 3 sold +$1.6B

    Bought by

    Sold by

    HUM: every holder and its history

  3. 3 STZ Constellation Brands Inc. 3 bought · 0 sold +$1.5B

    Bought by

    Sold by

    No manager sold.

    STZ: every holder and its history

  4. 4 ELV Elevance Health Inc. 7 bought · 2 sold +$1.5B
  5. 5 RDDT Reddit Inc. 3 bought · 5 sold +$1.4B
  6. 6 SCHW The Charles Schwab Corp. 3 bought · 5 sold +$1.3B
  7. 7 SBAC Sba Communications Corp. 3 bought · 2 sold +$1.3B
  8. 8 CVS Cvs Health Corp. 6 bought · 6 sold +$1B
  9. 9 CMCSA Comcast Corp. 4 bought · 2 sold +$960M
  10. 10 CSGP Costar Group Inc. 5 bought · 1 sold +$895M

Not counted as buying: 150 IPOs, spin-offs and new listings.

Most sold

  1. 1 AAPL Apple Inc. 7 bought · 15 sold −$15.7B
  2. 2 BAC Bank Amer Corp. 2 bought · 9 sold −$6.5B
  3. 3 BRK.B / BRK.A Berkshire Hathaway 4 bought · 10 sold −$3.3B
  4. 4 C Citigroup Inc. (C) 1 bought · 5 sold −$2.9B
  5. 5 GOOGL / GOOG Alphabet 17 bought · 24 sold −$2.7B

    Sold by

    and 16 more

    Bought by

    and 9 more

    GOOGL / GOOG: every holder and its history

  6. 6 CRM Salesforce Inc. 3 bought · 11 sold −$2.3B
  7. 7 WFC Wells Fargo & Co. 3 bought · 12 sold −$2.2B
  8. 8 AMZN Amazon Com Inc. 11 bought · 23 sold −$2.2B

    Sold by

    and 15 more

    Bought by

    and 3 more

    AMZN: every holder and its history

  9. 9 BABA Alibaba Group Holding, Ltd. 3 bought · 9 sold −$1.7B
  10. 10 TFC Truist Finl Corp. 2 bought · 3 sold −$1.3B

    Sold by

    Bought by

    TFC: every holder and its history

Not counted as selling: 160 mergers and delistings.

Opened and closed

New positions started from zero, and positions sold down to zero. IPOs, spin-offs and mergers are left out.

Opened by the most managers

  1. COF Capital One Financial Corp. 6 managers avg 2.8% of book · Chris James - Meritage Group, Stephen Mandel - Lone Pine Capital and 4 more
  2. MSFT Microsoft Corp. 6 managers avg 1.4% of book · Ram Parameswaran - Octahedron Capital Management, Gavin Baker - Atreides Management and 4 more
  3. UNH Unitedhealth Group Inc. 5 managers avg 1.2% of book · Andreas Halvorsen - Viking Global Investors, Senator Investment Group and 3 more
  4. NU Nu Hldgs Ltd 5 managers avg 0.78% of book · Dan Sundheim - D1 Capital Partners, Gavin Baker - Atreides Management and 3 more
  5. BA Boeing Co. 4 managers avg 8.5% of book · King Street Capital Management, Nehal Chopra - Ratan Capital Management and 2 more
  6. TSLA Tesla Inc. 4 managers avg 3.0% of book · Nehal Chopra - Ratan Capital Management, Lee Ainslie - Maverick Capital and 2 more
  7. CSGP Costar Group Inc. 4 managers avg 2.8% of book · Dennis Hong - Shawspring Partners, Polen Capital Management and 2 more
  8. ACHC Acadia Healthcare Company In 4 managers avg 2.4% of book · Eric Khrom - Khrom Capital Management, Sachem Head Capital Management and 2 more
  9. LLY Eli Lilly & Co. 4 managers avg 2.2% of book · Stephen Mandel - Lone Pine Capital, John Armitage - Egerton Capital (UK) and 2 more
  10. FERG Ferguson Enterprises Inc. 4 managers avg 1.8% of book · Seth Klarman - Baupost Group, Gavin Baker - Atreides Management and 2 more

Closed out by the most managers

  1. AAPL Apple Inc. 7 managers was avg 13.4% of book · Duan Yongping - H&H International Investment, Mala Gaonkar - Surgocap Partners and 5 more
  2. AVGO Broadcom Inc. 4 managers was avg 0.99% of book · Stanley Druckenmiller - Duquesne Family Office, Lee Ainslie - Maverick Capital and 2 more
  3. LINE Lineage Inc. 4 managers was avg 0.33% of book · Lee Ainslie - Maverick Capital, Brad Gerstner - Altimeter Capital Management and 2 more
  4. GEV Ge Vernova Inc. 3 managers was avg 6.2% of book · Mala Gaonkar - Surgocap Partners, Stephen Mandel - Lone Pine Capital and 1 more
  5. OXY Occidental Pete Corp. 3 managers was avg 3.4% of book · Francis Chou - Chou Associates Management, Duan Yongping - H&H International Investment and 1 more
  6. PDD Pdd Holdings Inc. 3 managers was avg 3.4% of book · Ram Parameswaran - Octahedron Capital Management, Duan Yongping - H&H International Investment and 1 more
  7. AMD Advanced Micro Devices Inc. 3 managers was avg 2.6% of book · Estuary Capital Management, Ben Hoskin - Value Aligned Research Advisors and 1 more
  8. ADBE Adobe Inc. 3 managers was avg 2.6% of book · Spencer Waxman - Shannon River Fund Management, David Tepper - Appaloosa and 1 more
  9. MSFT Microsoft Corp. 3 managers was avg 2.3% of book · Josh Tarasoff - Greenlea Lane Capital Management, Dan Sundheim - D1 Capital Partners and 1 more
  10. UBER Uber Technologies Inc. 3 managers was avg 1.9% of book · Estuary Capital Management, John Armitage - Egerton Capital (UK) and 1 more

Where the money went

Net bought by sector, with price moves taken out. Pick a sector to see its names.

Health Care lost weight (−0.5 pts) even though managers bought $7.9B of it: weight follows price, not buying. Names without a sector (funds, foreign listings, private shares): −$2.4B.

Who moved the most

The biggest new positions, measured against each manager’s own book, and the managers that traded the most of theirs.

Biggest new bets

  1. King Street Capital Management opened BA · Boeing Co. 29.2% of book
  2. Estuary Capital Management opened TAP · Molson Coors Beverage Co. 11.4% of book
  3. Nehal Chopra - Ratan Capital Management opened TSLA · Tesla Inc. 10.8% of book
  4. Alex Roepers - Atlantic Investment Management opened OSK · Oshkosh Corp. (OSK) 10.6% of book
  5. Jana Partners Management opened MKL · Markel Group, Inc. 9.2% of book
  6. Ben Hoskin - Value Aligned Research Advisors opened GEV · Ge Vernova Inc. 9.0% of book

Most active managers

  1. King Street Capital Management 2 opened · 2 closed · +$130M net 112% of book traded
  2. Ram Parameswaran - Octahedron Capital Management 8 opened · 5 closed · +$7M net 111% of book traded
  3. Duan Yongping - H&H International Investment 0 opened · 8 closed · −$17.3B net 104% of book traded
  4. Alex Roepers - Atlantic Investment Management 4 opened · 1 closed · −$14M net 94% of book traded
  5. Ben Hoskin - Value Aligned Research Advisors 11 opened · 8 closed · −$17M net 90% of book traded
  6. Dan Sundheim - D1 Capital Partners 16 opened · 15 closed · +$437M net 89% of book traded

What they hold

Most owned counts managers, with the change since last quarter. Largest is the share of the combined book, by dollars, so the biggest books lead it. Highest conviction is the average position among holders, three or more.

Most owned

  1. 1 GOOGL / GOOG Alphabet 71 managers +2
  2. 2 MSFT Microsoft Corp. 63 managers +3
  3. 3 AMZN Amazon Com Inc. 51 managers +4
  4. 4 META Meta Platforms Inc. 42 managers +1
  5. 5 BRK.B / BRK.A Berkshire Hathaway 35 managers −1
  6. 6 V Visa Inc. 34 managers +1
  7. 7 TSM Taiwan Semiconductor Mfg Ltd 33 managers +3
  8. 8 AAPL Apple Inc. 31 managers −3
  9. 9 UNH Unitedhealth Group Inc. 31 managers +4
  10. 10 MA Mastercard Inc. 29 managers +1

Largest

  1. 1 AAPL Apple Inc. 5.9% held by 31
  2. 2 MSFT Microsoft Corp. 3.5% held by 63
  3. 3 AXP American Express Co. 3.3% held by 16
  4. 4 GOOGL / GOOG Alphabet 3.2% held by 71
  5. 5 BAC Bank Amer Corp. 2.6% held by 21
  6. 6 META Meta Platforms Inc. 2.1% held by 42
  7. 7 AMZN Amazon Com Inc. 2.0% held by 51
  8. 8 KO Coca Cola Co. 1.8% held by 11
  9. 9 MCO Moodys Corp. 1.5% held by 19
  10. 10 V Visa Inc. 1.4% held by 34

Highest conviction

  1. 1 CVNA Carvana Co. avg 25.4% held by 9
  2. 2 LOAR Loar Holdings Inc. avg 14.9% held by 3
  3. 3 GPI Group 1 Automotive Inc. avg 10.5% held by 3
  4. 4 BRK.B / BRK.A Berkshire Hathaway avg 10.4% held by 35
  5. 5 I3N Chart Inds Inc. avg 10.1% held by 3
  6. 6 TDG Transdigm Group Inc. avg 10.1% held by 6
  7. 7 UTHR United Therapeutics Corp. avg 9.2% held by 3
  8. 8 SNX Td Synnex Corporation avg 8.8% held by 6
  9. 9 FICO Fair Isaac Corp. avg 8.6% held by 6
  10. 10 VFC Vf Corp. avg 8.5% held by 3

See all 2,388 names

Did the combined book beat SPY?

Each quarter’s combined book held to the next quarter-end, at the 13Fs’ own prices. Price only, no dividends, and today’s managers throughout. Nobody could have copied it: 13Fs arrive about 45 days after the quarter ends.

Combined book, 8 quarters +33.3% SPY +37.2% Difference −3.9 pts
2024 Q2, the start +0.0% Combined book +0.0% SPY 2024 Q3, since 2024 Q2 +6.9% Combined book +5.4% SPY That quarter: book +6.9%, SPY +5.4% 2024 Q4, since 2024 Q2 +8.1% Combined book +7.7% SPY That quarter: book +1.1%, SPY +2.1% 2025 Q1, since 2024 Q2 +6.0% Combined book +2.8% SPY That quarter: book −2.0%, SPY −4.6% 2025 Q2, since 2024 Q2 +14.5% Combined book +13.5% SPY That quarter: book +8.0%, SPY +10.5% 2025 Q3, since 2024 Q2 +21.7% Combined book +22.4% SPY That quarter: book +6.3%, SPY +7.8% 2025 Q4, since 2024 Q2 +24.9% Combined book +25.3% SPY That quarter: book +2.6%, SPY +2.4% 2026 Q1, since 2024 Q2 +19.6% Combined book +19.5% SPY That quarter: book −4.2%, SPY −4.6% 2026 Q2, since 2024 Q2 +33.3% Combined book +37.2% SPY That quarter: book +11.5%, SPY +14.8%
Quarter by quarter
Quarter Each manager once By dollars SPY Book − SPY Managers
2026 Q2 +14.5% +11.5% +14.8% −3.4 pts 133
2026 Q1 −4.4% −4.2% −4.6% +0.4 pts 136
2025 Q4 +2.1% +2.6% +2.4% +0.2 pts 136
2025 Q3 +9.1% +6.3% +7.8% −1.5 pts 136
2025 Q2 +11.6% +8.0% +10.5% −2.4 pts 136
2025 Q1 −3.8% −2.0% −4.6% +2.6 pts 136
2024 Q4 +2.6% +1.1% +2.1% −1.0 pts 134
2024 Q3 +7.5% +6.9% +5.4% +1.5 pts 133

All 2,388 names

Download CSV
Clear

Showing 300 of 350 matching names. The CSV has every name.

Ticker Company Sector Held by Weight, $ Net bought Bought / sold Opened / closed
UNH Unitedhealth Group Inc. Health Care 31 +4 0.65% −$578M 10 / 11 5 / 1
TMO Thermo Fisher Scientific Inc. Health Care 16 +1 0.22% +$460M 7 / 4 2 / 1
LLY Eli Lilly & Co. Health Care 15 +3 0.25% +$1.7B 8 / 3 4 / 1
DHR Danaher Corporation Health Care 15 −1 0.09% +$41M 3 / 8 1 / 2
JNJ Johnson & Johnson Health Care 14 −2 0.06% −$88M 2 / 5 0 / 2
ABBV Abbvie Inc. Health Care 13 +3 0.02% +$72M 4 / 1 3 / 0
CVS Cvs Health Corp. Health Care 12 −2 0.40% +$1B 6 / 6 1 / 3
ELV Elevance Health Inc. Health Care 12 0.38% +$1.5B 7 / 2 2 / 2
BMY Bristol-Myers Squibb Co. Health Care 12 0.14% +$121M 3 / 6 2 / 2
MRK Merck & Co. Inc. Health Care 12 −1 0.06% +$290M 3 / 5 2 / 3
HCA Hca Healthcare Inc. Health Care 11 0.40% +$72M 3 / 3 1 / 1
PFE Pfizer Inc. Health Care 11 0.05% +$315M 4 / 6 1 / 1
GEHC Ge Healthcare Technologies, Inc. Health Care 10 +1 0.18% +$204M 4 / 1 1 / 0
CI The Cigna Group Health Care 9 0.40% −$91M 1 / 3 0 / 0
BAX Baxter International, Inc. Health Care 9 +1 0.20% +$245M 3 / 4 1 / 0
ZBH Zimmer Biomet Holdings, Inc. Health Care 9 +1 0.16% +$294M 2 / 2 1 / 0
ABT Abbott Labs Health Care 9 0.12% −$144M 0 / 1 0 / 0
TEVA Teva Pharmaceutical Inds Ltd Health Care 9 0.05% +$118M 2 / 4 0 / 0
ILMN Illumina Inc. Health Care 9 +1 0.04% −$18M 3 / 5 2 / 1
HUM Humana, Inc. Health Care 8 0.32% +$1.6B 4 / 3 2 / 2
MDT Medtronic PLC Health Care 8 −2 0.16% −$221M 3 / 4 0 / 2
ZTS Zoetis Inc. Health Care 8 −1 0.15% +$168M 1 / 2 0 / 1
BDX Becton Dickinson & Co. Health Care 8 +1 0.09% +$431M 3 / 2 1 / 0
BSX Boston Scientific Corp. Health Care 8 0.05% +$9M 1 / 3 0 / 0
ICLR Icon PLC Health Care 8 +4 0.05% +$123M 5 / 3 4 / 0
EW Edwards Lifesciences Corp. Health Care 8 +1 <0.01% −$4M 2 / 4 2 / 1
AMGN Amgen Inc. Health Care 8 <0.01% +$10M 3 / 3 1 / 1
NTRA Natera Inc. Health Care 7 0.12% −$38M 1 / 2 0 / 0
NVO Novo-Nordisk A S Health Care 7 −1 0.06% −$68M 0 / 4 0 / 1
WST Western Alliance Bancorp Health Care 7 −1 0.05% −$167M 3 / 4 0 / 1
ISRG Intuitive Surgical Inc. Health Care 7 +1 0.04% −$114M 1 / 3 1 / 0
THC Tenet Healthcare Corp. Health Care 7 −2 0.03% −$124M 1 / 7 0 / 2
INSM Insmed Inc. Health Care 7 +1 0.02% −$502K 3 / 2 1 / 0
IQV Iqvia Hldgs Inc. Health Care 6 +1 0.23% +$267M 4 / 0 1 / 0
GSK Gsk PLC Health Care 6 0.17% +$13M 2 / 2 0 / 0
AVTR Avantor, Inc. Health Care 6 0.16% +$601M 3 / 2 0 / 0
DGX Quest Diagnostics Inc. Health Care 6 0.03% −$6M 0 / 1 0 / 0
BIIB Biogen Inc. Health Care 6 +1 0.01% +$63M 3 / 1 1 / 0
ALGN Align Technology Inc. Health Care 6 +1 <0.01% +$2M 4 / 1 1 / 0
SNY Sanofi SA Health Care 5 −2 0.26% −$66M 1 / 4 0 / 2
SYK Stryker Corporation Health Care 5 0.18% −$26M 0 / 0 0 / 0
CNC Centene Corp. Del Health Care 5 0.13% +$21M 3 / 2 2 / 2
REGN Regeneron Pharmaceuticals, Inc. Health Care 5 −2 0.12% −$28M 1 / 4 1 / 3
NVS Novartis AG Health Care 5 0.09% −$674K 1 / 1 0 / 0
SOLV Solventum Corporation Health Care 5 −2 0.07% +$61M 1 / 4 0 / 2
MCK Mckesson Corp. Health Care 5 +1 0.06% +$226M 1 / 2 1 / 0
CRL Charles Riv Labs Intl Inc. Health Care 5 0.04% +$171M 2 / 4 1 / 1
TECH Bio Techne Corp. Health Care 5 0.04% −$304K 1 / 2 0 / 0
OSCR Oscar Health Inc. Health Care 5 −1 0.02% −$14M 2 / 2 0 / 1
HSIC Henry Schein, Inc. Health Care 5 +1 0.02% +$137M 3 / 0 1 / 0
NAMS Newamsterdam Pharma Company Health Care 5 +1 0.02% −$32M 1 / 2 1 / 0
VEEV Veeva Sys Inc. Health Care 5 0.01% −$200M 2 / 3 1 / 1
ACHC Acadia Healthcare Company In Health Care 5 +1 0.01% −$103M 4 / 4 4 / 3
MEDP Medpace Holdings Inc. Health Care 5 +1 0.01% +$64M 4 / 0 1 / 0
BNTX Biontech Se Health Care 5 −1 <0.01% +$86M 2 / 1 0 / 1
GILD Gilead Sciences, Inc. Health Care 4 0.22% +$4M 2 / 1 0 / 0
BMRN Biomarin Pharmaceutical, Inc. Health Care 4 −1 0.14% +$83M 2 / 1 0 / 1
IDXX Idexx Labs Inc. Health Care 4 0.14% +$34M 1 / 0 0 / 0
INCY Incyte Corp. Health Care 4 0.08% +$760K 1 / 2 0 / 0
MTD Mettler Toledo International Health Care 4 +1 0.08% −$10M 1 / 0 1 / 0
VTRS Viatris Inc. Health Care 4 −2 0.07% +$2M 1 / 3 0 / 2
A Agilent Technologies Inc. Health Care 4 −1 0.05% −$148M 0 / 1 0 / 1
BIO Bio Rad Labs Inc. Health Care 4 0.04% +$57M 1 / 0 0 / 0
BHC Bausch Health Companies Inc. Health Care 4 −1 0.04% −$2M 0 / 1 0 / 1
NBIX Neurocrine Biosciences, Inc. Health Care 4 0.03% +$210M 2 / 1 0 / 0
NVST Envista Holdings Corporation Health Care 4 +1 0.03% +$3M 2 / 2 1 / 0
RPRX Royalty Pharma PLC Health Care 4 0.03% +$22M 2 / 1 0 / 0
COO Cooper Cos Inc. Health Care 4 +1 0.02% +$188M 2 / 0 1 / 0
BHVN Biohaven Ltd Health Care 4 0.01% +$21M 2 / 1 0 / 0
PCVX Vaxcyte Inc. Health Care 4 −1 <0.01% +$18M 2 / 3 0 / 1
HOLX Hologic, Inc. Health Care 4 <0.01% +$720K 3 / 1 1 / 1
RCKT Rocket Pharmaceuticals Inc. Health Care 4 <0.01% +$8M 3 / 1 0 / 0
EWTX Edgewise Therapeutics Inc. Health Care 4 +1 <0.01% −$7M 1 / 3 1 / 0
VRTX Vertex Pharmaceuticals Health Care 4 −1 <0.01% −$67M 0 / 4 0 / 1
SNDX Syndax Pharmaceuticals Inc. Health Care 4 <0.01% −$12M 0 / 1 0 / 0
CAH Cardinal Health Inc. Health Care 4 −3 <0.01% −$302M 0 / 3 0 / 3
ALKS Alkermes PLC Health Care 4 <0.01% −$3M 0 / 1 0 / 0
URGN Urogen Pharma Ltd Health Care 4 <0.01% −$1M 2 / 1 0 / 0
DVA Davita Inc. Health Care 3 0.39% −$3M 0 / 1 0 / 0
WAT Waters Corp. Health Care 3 0.12% +$4M 0 / 1 0 / 0
UHS Universal Hlth Svcs Inc. Health Care 3 −1 0.08% +$32M 1 / 1 0 / 1
ALNY Alnylam Pharmaceuticals, Inc. Health Care 3 0.06% −$19M 0 / 0 0 / 0
EXEL Exelixis Inc. Health Care 3 0.06% −$66M 1 / 1 0 / 0
ROIV Roivant Sciences Ltd Health Care 3 0.04% −$75M 0 / 1 0 / 0
RVMD Revolution Medicines Inc. Health Care 3 0.04% +$74M 2 / 1 0 / 0
BEAM Beam Therapeutics Inc. Health Care 3 0.03% +$14M 1 / 0 0 / 0
INSP Inspire Med Sys Inc. Health Care 3 +1 0.02% +$164M 2 / 0 1 / 0
PBH Prestige Consmr Healthcare I Health Care 3 0.02% −$2M 0 / 1 0 / 0
LH Labcorp Holdings Inc. Health Care 3 0.01% −$5M 0 / 1 0 / 0
IONS Ionis Pharmaceuticals Inc. Health Care 3 0.01% −$20M 0 / 2 0 / 0
Masimo Masimo Corp. Health Care 3 <0.01% −$149M 0 / 2 0 / 0
SHC Sotera Health Co. Health Care 3 <0.01% −$43M 1 / 1 1 / 1
CDNA Caredx Inc. Health Care 3 <0.01% −$6M 1 / 2 0 / 0
UTHR United Therapeutics Corp. Health Care 3 <0.01% +$1M 1 / 1 0 / 0
CNTA Centessa Pharmaceuticals PLC Health Care 3 <0.01% −$6M 1 / 2 0 / 0
SGRY Surgery Partners Inc. Health Care 3 −1 <0.01% +$22M 2 / 2 0 / 1
JAZZ Jazz Pharmaceuticals PLC Health Care 3 <0.01% −$28M 0 / 2 0 / 0
DXCM Dexcom Inc. Health Care 3 <0.01% −$4M 1 / 1 0 / 0
ASND Ascendis Pharma A/S Health Care 3 −1 <0.01% −$6M 1 / 2 0 / 1
DNA Ginkgo Bioworks Holdings Inc. Health Care 3 <0.01% +$906K 1 / 1 0 / 0
IMVT Immunovant Inc. Health Care 3 −2 <0.01% −$24M 1 / 3 0 / 2
XENE Xenon Pharmaceuticals Inc. Health Care 3 <0.01% −$13M 0 / 1 0 / 0
GKOS Glaukos Corp. Health Care 3 <0.01% −$26M 0 / 1 0 / 0
KYMR Kymera Therapeutics Inc. Health Care 3 +1 <0.01% +$5M 1 / 0 1 / 0
RARE Ultragenyx Pharmaceutical In Health Care 3 −1 <0.01% −$17M 0 / 3 0 / 1
LXEO Lexeo Therapeutics Inc. Health Care 3 +1 <0.01% −$199K 2 / 1 1 / 0
AXSM Axsome Therapeutics Inc. Health Care 3 <0.01% −$9M 1 / 1 0 / 0
BKD Brookdale Sr Living Inc. Health Care 3 +1 <0.01% −$2M 2 / 1 1 / 0
DYN Dyne Therapeutics Inc. Health Care 3 <0.01% −$6M 0 / 2 0 / 0
NUVB Nuvation Bio Inc. Health Care 3 <0.01% $0 0 / 0 0 / 0
PGNY Progyny Inc. Health Care 3 +1 <0.01% −$15M 1 / 2 1 / 0
BCYC Bicycle Therapeutics Plc-Adr Health Care 3 −1 <0.01% −$23K 1 / 1 0 / 1
STOK Stoke Therapeutics Inc. Health Care 3 +1 <0.01% −$125K 1 / 1 1 / 0
ELAN Elanco Animal Health, Inc. Health Care 2 −1 0.07% −$4M 0 / 1 0 / 1
BBIO Bridgebio Pharma Inc. Health Care 2 0.06% +$67M 1 / 0 0 / 0
MDGL Madrigal Pharmaceuticals Inc. Health Care 2 0.04% $0 0 / 0 0 / 0
LNTH Lantheus Hldgs Inc. Health Care 2 0.03% +$211M 2 / 0 0 / 0
FMS Fresenius Medical Care AG Health Care 2 0.03% −$21M 0 / 1 0 / 0
CRSP Crispr Therapeutics AG Health Care 2 0.03% +$58M 1 / 0 0 / 0
XRAY Dentsply Sirona Inc. Health Care 2 0.02% +$7M 0 / 0 0 / 0
TWST Twist Bioscience Corp. Health Care 2 0.02% −$4M 0 / 1 0 / 0
PRVA Privia Health Group Inc. Health Care 2 −1 0.02% −$3M 0 / 2 0 / 1
ADPT Adaptive Biotechnologies Cor Health Care 2 0.02% −$13M 0 / 1 0 / 0
PTGX Protagonist Therapeutics Inc. Health Care 2 0.02% +$3M 0 / 0 0 / 0
CRNX Crinetics Pharmaceuticals In Health Care 2 −1 0.02% +$133M 1 / 2 0 / 1
WGS Genedx Holdings Corp. Health Care 2 +1 0.01% +$15M 1 / 0 1 / 0
FTRE Fortrea Hldgs Inc. Health Care 2 −3 0.01% −$51M 1 / 4 0 / 3
VCYT Veracyte Inc. Health Care 2 0.01% −$38M 0 / 2 0 / 0
DOCS Doximity Inc. Health Care 2 +1 0.01% −$225M 1 / 1 1 / 0
ITGR Integer Hldgs Corp. Health Care 2 0.01% +$11M 1 / 0 0 / 0
SDGR Schrodinger Inc. Health Care 2 0.01% −$2M 0 / 1 0 / 0
INDV Indivior PLC Health Care 2 <0.01% −$10M 0 / 1 0 / 0
NEOG Neogen Corp. Health Care 2 <0.01% +$14M 1 / 0 0 / 0
WVE Wave Life Sciences Ltd Health Care 2 +1 <0.01% −$21M 1 / 1 1 / 0
OGN Organon & Company Health Care 2 <0.01% −$7M 0 / 1 0 / 0
NVAX Novavax Inc. Health Care 2 −1 <0.01% −$7M 1 / 1 0 / 1
BLCO Bausch Plus Lomb Corp. Health Care 2 −1 <0.01% +$3M 1 / 1 0 / 1
LFST Lifestance Health Group Inc. Health Care 2 <0.01% −$3M 1 / 1 0 / 0
HQY Healthequity Inc. Health Care 2 <0.01% +$3M 0 / 0 0 / 0
FOLD Amicus Therapeutics Inc. Health Care 2 <0.01% −$5M 0 / 1 0 / 0
Perrigo Perrigo Company PLC Health Care 2 <0.01% +$315K 1 / 1 1 / 1
ARVN Arvinas Inc. Health Care 2 <0.01% +$5M 1 / 1 0 / 0
LQDA Liquidia Corporation Health Care 2 <0.01% $0 0 / 0 0 / 0
WAY Waystar Hldg Corp. IPO or spin-off Health Care 2 +2 <0.01% +$58M 2 / 0 2 / 0
BTI British Amern Tob PLC Health Care 2 <0.01% −$507K 1 / 1 0 / 0
EMBC Embecta Corp. Health Care 2 <0.01% −$3M 0 / 1 0 / 0
TVTX Travere Therapeutics Inc. Health Care 2 +1 <0.01% +$51M 1 / 0 1 / 0
EHC Encompass Health Corp. Health Care 2 <0.01% +$41M 1 / 1 0 / 0
BFLY Butterfly Network Inc. Health Care 2 <0.01% −$8M 0 / 1 0 / 0
ORIC Oric Pharmaceuticals Inc. Health Care 2 <0.01% +$2M 1 / 1 0 / 0
NVCR Novocure Ltd Health Care 2 <0.01% +$7M 1 / 0 0 / 0
IDYA Ideaya Biosciences Inc. Health Care 2 <0.01% −$6M 1 / 1 0 / 0
PHG Koninklijke Philips NV Health Care 2 <0.01% +$8M 2 / 0 0 / 0
SRTA Blade Air Mobility Inc. Health Care 2 +1 <0.01% +$6M 2 / 0 1 / 0
NRIX Nurix Therapeutics Inc. Health Care 2 −1 <0.01% −$15M 0 / 3 0 / 1
AVAH Aveanna Healthcare Hldgs Inc. Health Care 2 +1 <0.01% +$2M 1 / 0 1 / 0
MIRM Mirum Pharmaceuticals Inc. Health Care 2 <0.01% −$3M 0 / 1 0 / 0
RGEN Repligen Corp. Health Care 2 <0.01% −$233K 1 / 0 0 / 0
ALVO Alvotech SA Health Care 2 <0.01% −$8M 0 / 1 0 / 0
GRFS Grifols S A Health Care 2 −1 <0.01% −$4M 0 / 1 0 / 1
TRVI Trevi Therapeutics Inc. Health Care 2 <0.01% −$1M 0 / 1 0 / 0
CYTK Cytokinetics Inc. Health Care 2 −2 <0.01% −$9M 0 / 3 0 / 2
ENTA Enanta Pharmaceuticals Inc. Health Care 2 <0.01% $0 0 / 0 0 / 0
IOVA Iovance Biotherapeutics Inc. Health Care 2 <0.01% $0 0 / 0 0 / 0
VKTX Viking Therapeutics Inc. Health Care 2 −1 <0.01% −$35M 0 / 3 0 / 1
PRME Prime Medicine Inc. Health Care 2 −1 <0.01% −$4M 0 / 2 0 / 1
LKFT Galapagos NV Health Care 2 <0.01% $0 0 / 0 0 / 0
ENOV Enovis Corporation Health Care 2 <0.01% +$3M 2 / 0 0 / 0
NUVL Nuvalent Inc. Health Care 2 <0.01% −$431K 0 / 1 0 / 0
AXGN Axogen Inc. Health Care 2 <0.01% −$1M 0 / 1 0 / 0
TALK Talkspace Inc. Health Care 2 −1 <0.01% −$5M 1 / 2 0 / 1
CATX Perspective Therapeutics Inc. Health Care 2 <0.01% −$3M 0 / 2 0 / 0
RDNT Radnet Inc. Health Care 2 <0.01% −$1M 0 / 1 0 / 0
CMPS Compass Pathways PLC Health Care 2 <0.01% −$1M 0 / 1 0 / 0
PEPG Pepgen Inc. Health Care 2 <0.01% −$262K 0 / 1 0 / 0
IVVD Invivyd Inc. Health Care 2 <0.01% $0 0 / 0 0 / 0
BRKR Bruker Corp. Health Care 2 +1 <0.01% +$3M 1 / 1 1 / 0
BWAY Brainsway Ltd Health Care 2 +1 <0.01% +$1M 1 / 1 1 / 0
ALLO Allogene Therapeutics Inc. Health Care 2 <0.01% +$406K 1 / 0 0 / 0
COGT Cogent Biosciences Inc. Health Care 2 <0.01% −$6M 0 / 1 0 / 0
TSHA Taysha Gene Therapies Inc. Health Care 2 +1 <0.01% +$904K 1 / 0 1 / 0
VNDA Vanda Pharmaceuticals Inc. Health Care 2 <0.01% −$6M 0 / 1 0 / 0
DCGO Docgo Inc. IPO or spin-off Health Care 2 +2 <0.01% +$2M 2 / 0 2 / 0
CBLL Ceribell Inc. IPO or spin-off Health Care 2 +2 <0.01% +$905K 2 / 0 2 / 0
Compugen Compugen Ltd Health Care 2 −1 <0.01% −$2M 0 / 1 0 / 1
COR Cencora Inc. Health Care 2 +1 <0.01% −$52M 1 / 1 1 / 0
OSUR Orasure Technologies Inc. Health Care 2 +1 <0.01% +$36K 1 / 0 1 / 0
ALC Alcon AG Health Care 1 −1 0.04% −$30M 0 / 2 0 / 1
RXRX Recursion Pharmaceuticals Inc. Health Care 1 0.02% −$3M 0 / 0 0 / 0
HIMS Hims & Hers Health Inc. Health Care 1 −1 0.01% +$186M 1 / 1 0 / 1
AGIO Agios Pharmaceuticals Inc. Health Care 1 0.01% +$447K 0 / 0 0 / 0
ARGX Argenx Se Health Care 1 −1 0.01% −$28M 0 / 1 0 / 1
MOH Molina Healthcare Inc. Health Care 1 <0.01% −$166M 0 / 1 0 / 0
HROW Harrow Health Inc. Health Care 1 <0.01% $0 0 / 0 0 / 0
PHVS Pharvaris N V Health Care 1 <0.01% $0 0 / 0 0 / 0
TGTX Tg Therapeutics Inc. Health Care 1 <0.01% −$602K 0 / 0 0 / 0
DNTH Dianthus Therapeutics Inc. Health Care 1 <0.01% −$964K 0 / 0 0 / 0
TFX Teleflex Incorporated Health Care 1 <0.01% +$29M 1 / 0 0 / 0
MYGN Myriad Genetics Inc. Health Care 1 <0.01% +$40M 1 / 0 0 / 0
ALHC Alignment Healthcare Inc. Health Care 1 <0.01% −$10M 0 / 1 0 / 0
ACAD Acadia Pharmaceuticals Inc. Health Care 1 <0.01% +$4M 1 / 0 0 / 0
ZLAB Zai Lab Ltd Health Care 1 −1 <0.01% −$51M 0 / 1 0 / 1
GH Guardant Health Inc. Health Care 1 <0.01% −$2M 0 / 0 0 / 0
PSNL Personalis Inc. Health Care 1 <0.01% −$2M 0 / 0 0 / 0
USNA Usana Health Sciences Inc. Health Care 1 <0.01% +$1M 0 / 0 0 / 0
ETON Eton Pharmaceuticals Inc. Health Care 1 <0.01% +$960K 0 / 0 0 / 0
OCUL Ocular Therapeutix Inc. Health Care 1 <0.01% −$6M 0 / 1 0 / 0
ESTA Establishment Labs Hldgs Inc. Health Care 1 −1 <0.01% +$4M 1 / 1 0 / 1
TECX Tectonic Therapeutic Inc. Health Care 1 <0.01% +$9M 1 / 0 0 / 0
ARCT Arcturus Therapeutics Holdings Health Care 1 <0.01% −$3M 0 / 1 0 / 0
CERS Cerus Corp. Health Care 1 <0.01% +$4M 1 / 0 0 / 0
CGON Cg Oncology Inc. Health Care 1 <0.01% −$16M 0 / 1 0 / 0
STXS Stereotaxis Inc. Health Care 1 <0.01% $0 0 / 0 0 / 0
CAPR Capricor Therapeutics Inc. IPO or spin-off Health Care 1 +1 <0.01% +$31M 1 / 0 1 / 0
RYTM Rhythm Pharmaceuticals Inc. Health Care 1 <0.01% $0 0 / 0 0 / 0
INBX Inhibrx Biosciences Inc. Health Care 1 <0.01% $0 0 / 0 0 / 0
LFCR Lifecore Biomedical Inc. Health Care 1 <0.01% +$10M 1 / 0 0 / 0
PRTA Prothena Corp. PLC Health Care 1 <0.01% $0 0 / 0 0 / 0
CRMD Cormedix Inc. Health Care 1 <0.01% +$11M 1 / 0 0 / 0
ABSI Absci Corp. Health Care 1 <0.01% +$5M 1 / 0 0 / 0
PGEN Precigen Inc. Health Care 1 <0.01% −$63K 0 / 0 0 / 0
ATRC Atricure Inc. Health Care 1 <0.01% $0 0 / 0 0 / 0
HSTM Healthstream Inc. Health Care 1 <0.01% −$203K 0 / 0 0 / 0
AORT Artivion Inc. Health Care 1 <0.01% −$862K 0 / 0 0 / 0
Enhabit Enhabit Inc. Health Care 1 <0.01% $0 0 / 0 0 / 0
Bausch Lomb Bausch Lomb Corp. IPO or spin-off Health Care 1 +1 <0.01% +$15M 1 / 0 1 / 0
VYGR Voyager Therapeutics Inc. Health Care 1 <0.01% +$2M 1 / 0 0 / 0
TYRA Tyra Biosciences Inc. IPO or spin-off Health Care 1 +1 <0.01% +$14M 1 / 0 1 / 0
TNGX Tango Therapeutics Inc. IPO or spin-off Health Care 1 +1 <0.01% +$12M 1 / 0 1 / 0
EOLS Evolus Inc. Health Care 1 <0.01% +$3M 1 / 0 0 / 0
MRVI Maravai Lifesciences Hldgs I Health Care 1 <0.01% +$436K 0 / 0 0 / 0
TMDX Transmedics Group Inc. Health Care 1 −1 <0.01% +$8M 1 / 1 0 / 1
ARWR Arrowhead Pharmaceuticals In IPO or spin-off Health Care 1 +1 <0.01% +$12M 1 / 0 1 / 0
SNN Smith & Nephew PLC Health Care 1 <0.01% +$10M 1 / 1 1 / 1
PHAT Phathom Pharmaceuticals Inc. Health Care 1 <0.01% −$3M 0 / 1 0 / 0
ANAB Anaptysbio Inc. Health Care 1 −1 <0.01% −$2M 0 / 1 0 / 1
PNTG Pennant Group Inc. Health Care 1 <0.01% +$957K 1 / 0 0 / 0
COYA Coya Therapeutics Inc. Health Care 1 <0.01% +$2M 1 / 0 0 / 0
DMAC Diamedica Therapeutics Inc. Health Care 1 <0.01% +$615K 1 / 0 0 / 0
GUTS Fractyl Health Inc. Health Care 1 <0.01% $0 0 / 0 0 / 0
RDY Dr Reddy's Laboratories Ltd Health Care 1 <0.01% +$7M 1 / 0 0 / 0
AHCO Adapthealth Corp. Health Care 1 <0.01% −$698K 0 / 1 0 / 0
TNDM Tandem Diabetes Care Inc. Health Care 1 <0.01% +$684K 1 / 0 0 / 0
MRNA Moderna Inc. Health Care 1 −1 <0.01% −$45M 1 / 2 1 / 2
CNTX Context Therapeutics Inc. Health Care 1 <0.01% +$63K 0 / 0 0 / 0
INFU Infusystem Hldgs Inc. Health Care 1 <0.01% +$2M 1 / 0 0 / 0
TAK Takeda Pharmaceutical Co. Ltd Health Care 1 <0.01% −$10M 0 / 1 0 / 0
Select Med Select Med Hldgs Corp. Health Care 1 <0.01% +$1M 1 / 0 0 / 0
Kalvista Pharmaceutic… Kalvista Pharmaceuticals Inc. Health Care 1 <0.01% +$745K 1 / 0 0 / 0
SUPN Supernus Pharmaceuticals, Inc. Health Care 1 <0.01% $0 0 / 0 0 / 0
ORKA Oruka Therapeutics Inc. Health Care 1 <0.01% −$9M 0 / 1 0 / 0
XOMA Xoma Corp. Del Health Care 1 <0.01% $0 0 / 0 0 / 0
LZAGY Lonza Group Adr Health Care 1 <0.01% +$54K 0 / 0 0 / 0
ATEC Alphatec Hldgs Inc. Health Care 1 <0.01% +$2M 1 / 0 0 / 0
CON Concentra Group Holdings Par Health Care 1 <0.01% +$903K 1 / 1 1 / 1
COLL Collegium Pharmaceutical Inc. Health Care 1 <0.01% +$594K 1 / 0 0 / 0
SYRE Spyre Therapeutics Inc. Health Care 1 <0.01% +$2M 1 / 0 0 / 0
ZNTL Zentalis Pharmaceuticals Inc. Health Care 1 <0.01% +$2M 1 / 0 0 / 0
BCRX Biocryst Pharmaceuticals Inc. Health Care 1 <0.01% $0 0 / 0 0 / 0
AZTA Azenta Inc. IPO or spin-off Health Care 1 +1 <0.01% +$5M 1 / 0 1 / 0
TELA Tela Bio Inc. IPO or spin-off Health Care 1 +1 <0.01% +$4M 1 / 0 1 / 0
PRQR Proqr Therapeutics N V Health Care 1 <0.01% +$2M 1 / 0 0 / 0
QURE Uniqure NV Health Care 1 <0.01% −$8M 0 / 1 0 / 0
KURA Kura Oncology Inc. Health Care 1 <0.01% +$348K 1 / 0 0 / 0
RCUS Arcus Biosciences Inc. Health Care 1 <0.01% −$37K 0 / 0 0 / 0
ANGO Angiodynamics Inc. Health Care 1 <0.01% +$149K 0 / 0 0 / 0
CERT Certara Inc. Health Care 1 <0.01% +$799K 1 / 0 0 / 0
PODD Insulet Corp. Health Care 1 <0.01% −$914K 0 / 1 0 / 0
IART Integra Lifesciences Hldgs Health Care 1 −1 <0.01% −$56M 0 / 2 0 / 1
ABCL Abcellera Biologics Inc. Health Care 1 <0.01% +$483K 1 / 0 0 / 0
HALO Halozyme Therapeutics Health Care 1 <0.01% +$17K 0 / 0 0 / 0
VMD Viemed Healthcare Inc. Health Care 1 <0.01% +$2M 1 / 0 0 / 0
SIBN Si-Bone Inc. IPO or spin-off Health Care 1 +1 <0.01% +$3M 1 / 0 1 / 0
ARAY Accuray Inc. Health Care 1 <0.01% $0 0 / 0 0 / 0
RZLT Rezolute Inc. Health Care 1 <0.01% −$8K 0 / 0 0 / 0
Nanox Imaging Nanox Imaging Ltd Health Care 1 <0.01% +$346K 1 / 0 0 / 0
INGN Inogen Inc. Health Care 1 <0.01% $0 0 / 0 0 / 0
BCAX Bicara Therapeutics Inc. Health Care 1 −1 <0.01% +$1M 1 / 2 1 / 2
CVRX Cvrx Inc. Health Care 1 <0.01% −$1K 0 / 0 0 / 0
MLYS Mineralys Therapeutics Inc. Health Care 1 <0.01% $0 0 / 0 0 / 0
Inmode Inmode Ltd Health Care 1 <0.01% −$106K 0 / 1 0 / 0
ALEC Alector Inc. Health Care 1 <0.01% $0 0 / 0 0 / 0
IPSC Century Therapeutics Inc. Health Care 1 <0.01% $0 0 / 0 0 / 0
PYXS Pyxis Oncology Inc. Health Care 1 <0.01% +$1M 1 / 0 0 / 0
LRMR Larimar Therapeutics Inc. Health Care 1 <0.01% −$475K 0 / 1 0 / 0
VCEL Vericel Corp. Health Care 1 <0.01% $0 0 / 0 0 / 0
ACRS Aclaris Therapeutics Inc. Health Care 1 <0.01% $0 0 / 0 0 / 0
AUTL Autolus Therapeutics PLC Health Care 1 <0.01% +$235K 1 / 0 0 / 0
GANX Gain Therapeutics Inc. Health Care 1 <0.01% $0 0 / 0 0 / 0
NGNE Neurogene Inc. Health Care 1 −1 <0.01% −$9M 1 / 1 0 / 1
ALDX Aldeyra Therapeutics Inc. Health Care 1 <0.01% $0 0 / 0 0 / 0
CRBU Caribou Biosciences Inc. Health Care 1 <0.01% $0 0 / 0 0 / 0
APYX Apyx Med Corp. Health Care 1 <0.01% $0 0 / 0 0 / 0
GPCR Structure Therapeutics Inc. Health Care 1 −1 <0.01% −$12M 0 / 1 0 / 1
SPRY Ars Pharmaceuticals Inc. Health Care 1 −1 <0.01% −$6M 0 / 2 0 / 1
IBIO Ibio Inc. Health Care 1 <0.01% $0 0 / 0 0 / 0
AMN Amn Healthcare Svcs Inc. Health Care 1 <0.01% −$160K 0 / 1 0 / 0
FHTX Foghorn Therapeutics Inc. Health Care 1 <0.01% +$704K 1 / 0 0 / 0
PVLA Palvella Therapeutics Inc. IPO or spin-off Health Care 1 +1 <0.01% +$857K 1 / 0 1 / 0
VIR Vir Biotechnology Inc. IPO or spin-off Health Care 1 +1 <0.01% +$734K 1 / 0 1 / 0

How the numbers work

Same managers in both quarters

Changes compare only managers with a 13F in both 2024 Q3 and 2024 Q4: 134 this time. New in 2024 Q4: Situational Awareness, Kentucky Trust Co. - Kentucky Trust.

Buying versus price

Each holding’s dollar change splits into price (what last quarter’s shares earned by this quarter’s 13F price) and net bought (shares added or cut, times this quarter’s price), using each 13F’s own values. The two add back to the change exactly. Stock splits are adjusted first.

Who counts as a buyer or a seller

A manager bought a stock if it opened a position, or added at least 5% to its shares or a trade worth 0.25% of its book; it sold if it closed the position or cut it by the same amounts. Smaller changes count as holding, and a stock split never counts. A manager was a net buyer for the quarter when its trading added up to at least 0.25% of its book. GOOG and GOOGL count once.

IPOs, spin-offs and mergers

A stock no tracked manager held last quarter (an IPO, a spin-off, a new share class) is not counted as buying, and one nobody holds now (a merger, a delisting) is not counted as selling. Choose them under All names to see them.

Each manager once, or by dollars

By default every manager counts the same, so a list leads with what the most managers did. By dollars ranks by money moved and weighs holdings by size, so the largest books set the order.

Sectors

GICS sectors where the company has one. Funds, foreign listings and private shares have none; their buying is shown on its own, never filed under Other. Sector weights are shares of the names that have a sector.

The combined book against SPY

Each quarter-end’s combined book is held to the next quarter-end at the 13Fs’ own prices: price only, no dividends, and today’s featured managers for every quarter. SPY is the same filings’ price for SPY. It is a record of what the managers held, not something anyone could have copied, because 13Fs arrive about 45 days after the quarter ends.

What a 13F leaves out

Long US-listed stock only: no shorts, cash, bonds or foreign listings, and options are left out here.